sarcodonin-g and Neoplasms

sarcodonin-g has been researched along with Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for sarcodonin-g and Neoplasms

ArticleYear
Anti-proliferative and apoptosis-inducible activity of Sarcodonin G from Sarcodon scabrosus in HeLa cells.
    International journal of oncology, 2009, Volume: 34, Issue:1

    There is an ongoing search for plant-derived diterpenes, especially for diterpenes with anti-inflammatory activity that also have anti-proliferative effects on human cancer cells. A cyathane-type diterpene, Sarcodonin G (SG), isolated from the mushroom Sarcodon scabrosus and already reported to have anti-inflammatory activity, inhibited proliferation of HeLa cells to the greatest extent among 4 cyathane diterpenes tested. SG showed an IC50 (50% inhibition concentration) of 20 microM, estimated by MTT assay 2 days after culture of cells with the chemical. SG treatment of HeLa cells resulted in dose-dependent generation of apoptotic events such as DNA-laddering (< or =100 microM). Moreover, SG-treated HeLa cells showed activation of caspase-3 and caspase-9 and increase of Bax/Bcl-2 ratios, as analyzed by Western blot analysis. The anti-proliferative effects of SG treatment on HeLa cells were lessened by a caspase inhibitor, Z-VAD-FMK. SG also showed anti-proliferative effects toward 5 other human cancer cell lines with IC50 values of 20-40 microM. Because of these anti-proliferative effects via possible caspase activation, SG holds promise of being a novel anti-proliferative agent deserving further investigation.

    Topics: Apoptosis; Basidiomycota; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Cycle; Cell Proliferation; Diterpenes; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Humans; Immunoblotting; Neoplasms; Proto-Oncogene Proteins c-bcl-2

2009